Matthew Buckhalter Sells 17,448 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 17,448 shares of the company’s stock in a transaction dated Tuesday, December 30th. The shares were sold at an average price of $8.36, for a total transaction of $145,865.28. Following the transaction, the chief financial officer owned 472,609 shares in the company, valued at $3,951,011.24. The trade was a 3.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Matthew Buckhalter also recently made the following trade(s):

• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total transaction of $143,969.00.
• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $141,424.02.

Aveanna Healthcare Trading Down 1.1%

AVAH opened at $8.08 on Friday. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The stock’s 50 day moving average price is $8.92 and its 200-day moving average price is $7.51. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The company had revenue of $450.53 million during the quarter. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AVAH. Truist Financial lifted their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday, November 7th. Jefferies Financial Group lifted their price target on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Royal Bank Of Canada increased their price objective on Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a research note on Friday, October 24th. Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Finally, William Blair started coverage on Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating on the stock. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $10.69.

Institutional Trading of Aveanna Healthcare

Hedge funds have recently bought and sold shares of the stock. Dynamic Technology Lab Private Ltd boosted its position in Aveanna Healthcare by 8.9% during the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares in the last quarter. Barclays PLC lifted its stake in shares of Aveanna Healthcare by 0.8% during the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after purchasing an additional 1,366 shares during the last quarter. Franklin Resources Inc. boosted its position in Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after purchasing an additional 1,528 shares in the last quarter. Olympiad Research LP grew its stake in Aveanna Healthcare by 7.5% in the third quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock valued at $280,000 after purchasing an additional 2,200 shares during the last quarter. Finally, Rhumbline Advisers raised its holdings in Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock worth $410,000 after purchasing an additional 2,918 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.